Partillion Bioscience

📍 Los Angeles, United States🗓 Founded 2020👥 21 employees💰 Last funded Apr 2023
Biotechnology🌐 partillion.com
Website LinkedIn
Partillion Bioscience is an early stage life science company aiming to democratize advanced single-cell assays with its award-winning nanovial platform. Our novel platform allows the rapid compartmentalization and analysis of millions of single cells to probe biological function such as secreted proteins. The validated technology underpinning Partillion’s products has been featured in notable journals such as Science Advances, Advanced Functional Materials, and Lab on Chip and received industry accolades, winning the 2020 SLAS Innovation Award.
3
Total investors
1
Early stage
2
Mid stage
0
Late stage
2020
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
3
Investor activity2020–2023 · investors recorded per year
2020120232
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Partillion Bioscience?
Partillion Bioscience has 3 investors on record on gritt.io, including 1 early-stage backers, 2 mid-stage.
When did Partillion Bioscience last raise funding?
The most recent investment in Partillion Bioscience recorded on gritt.io was in April 2023.
When was Partillion Bioscience founded?
Partillion Bioscience was founded in 2020.
What industry is Partillion Bioscience in?
Partillion Bioscience operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Partillion Bioscience based?
Partillion Bioscience is headquartered in Los Angeles, United States.